Tower Research Capital (TRC)’s Y-mAbs Therapeutics YMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$51.8K Buy
11,494
+6,474
+129% +$29.2K ﹤0.01% 2942
2025
Q1
$22.2K Buy
5,020
+3,378
+206% +$15K ﹤0.01% 2861
2024
Q4
$12.9K Sell
1,642
-3,748
-70% -$29.3K ﹤0.01% 3577
2024
Q3
$70.9K Sell
5,390
-1,512
-22% -$19.9K ﹤0.01% 2509
2024
Q2
$83.4K Buy
6,902
+3,516
+104% +$42.5K ﹤0.01% 2710
2024
Q1
$55.1K Sell
3,386
-3,300
-49% -$53.7K ﹤0.01% 2208
2023
Q4
$45.6K Buy
6,686
+5,185
+345% +$35.4K ﹤0.01% 3195
2023
Q3
$8.18K Buy
1,501
+88
+6% +$480 ﹤0.01% 4382
2023
Q2
$9.59K Sell
1,413
-4,486
-76% -$30.5K ﹤0.01% 4225
2023
Q1
$30K Buy
5,899
+5,323
+924% +$27.1K ﹤0.01% 3006
2022
Q4
$3K Sell
576
-1,008
-64% -$5.25K ﹤0.01% 5252
2022
Q3
$23K Sell
1,584
-2,600
-62% -$37.8K ﹤0.01% 3830
2022
Q2
$63K Buy
4,184
+1,304
+45% +$19.6K ﹤0.01% 2676
2022
Q1
$34K Sell
2,880
-295
-9% -$3.48K ﹤0.01% 3043
2021
Q4
$52K Buy
3,175
+932
+42% +$15.3K ﹤0.01% 2735
2021
Q3
$64K Buy
2,243
+448
+25% +$12.8K ﹤0.01% 2765
2021
Q2
$61K Sell
1,795
-2,254
-56% -$76.6K ﹤0.01% 2864
2021
Q1
$122K Buy
4,049
+1,250
+45% +$37.7K ﹤0.01% 2437
2020
Q4
$138K Buy
2,799
+1,832
+189% +$90.3K ﹤0.01% 2055
2020
Q3
$37K Sell
967
-1,716
-64% -$65.7K ﹤0.01% 3656
2020
Q2
$116K Buy
+2,683
New +$116K ﹤0.01% 2325
2020
Q1
Sell
-552
Closed -$17K 4025
2019
Q4
$17K Buy
+552
New +$17K ﹤0.01% 2042
2019
Q3
Sell
-740
Closed -$17K 4570
2019
Q2
$17K Buy
740
+525
+244% +$12.1K ﹤0.01% 2281
2019
Q1
$6K Sell
215
-142
-40% -$3.96K ﹤0.01% 2983
2018
Q4
$7K Buy
+357
New +$7K ﹤0.01% 2726